Chemoinformaics analysis of Cannabichromenic-Acid
| Molecular Weight | 358.478 | nRot | 8 |
| Heavy Atom Molecular Weight | 328.238 | nRig | 14 |
| Exact Molecular Weight | 358.214 | nRing | 2 |
| Solubility: LogS | -3.487 | nHRing | 1 |
| Solubility: LogP | 6.774 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 59.9518 |
| nHD | 2 | BPOL | 32.7002 |
| QED | 0.568 |
| Synth | 4.158 |
| Natural Product Likeliness | 1.714 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.004 |
| HIA | 0.013 |
| CACO-2 | -4.775 |
| MDCK | 0.0000265 |
| BBB | 0.078 |
| PPB | 0.977431 |
| VDSS | 1.776 |
| FU | 0.0445035 |
| CYP1A2-inh | 0.388 |
| CYP1A2-sub | 0.254 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.296 |
| CYP2c9-inh | 0.268 |
| CYP2c9-sub | 0.284 |
| CYP2d6-inh | 0.373 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.096 |
| CYP3a4-sub | 0.038 |
| CL | 2.05 |
| T12 | 0.357 |
| hERG | 0.068 |
| Ames | 0.003 |
| ROA | 0.064 |
| SkinSen | 0.662 |
| Carcinogencity | 0.35 |
| EI | 0.042 |
| Respiratory | 0.747 |
| NR-Aromatase | 0.04 |
| Antiviral | No |
| Prediction | 0.722002 |